Martin O’rourke
Employees
Charles River Laboratories
France
Biography
Martin O’Rourke has been working in oncology drug discovery for more than 10 years. His initial postdoctoral research focus was in vitro and in vivo models of angiogenesis within the drug discovery group at Queen’s University, Belfast (UK). This research led to the discovery of the endogenous protein FKBPL, ultimately identifying a derived peptide as a potent anti-angiogenic agent in prostate cancer models. Martin joined Charles River as a group leader, then became department director. Following this appointment, he took a short leave to serve as Head of Biology with Kesios Therapeutics, leading their clinical candidate back-up project, then returned to Charles River and the Integrated Drug Discovery team. Dr. O’Rourke is a member of the Irish Association of Cancer Research and American Association of Cancer Research. His research has appeared in 21 peer-reviewed papers and has yielded 6 patents.
Research Interest
Oncology
